Archive for March, 2013

« Previous Entries

Humira Safe for Arthritis

Sunday, March 31st, 2013

Humira (generic name, adalimumab), is a medication indicated for a number of health conditions, including Crohn’s disease and rheumatoid arthritis. However, because it is indicated for so many conditions, experts were worried that patients will have different reactions to the medicine, and some may them may be dangerous. Recent studies have shown that the medication [...]

OAB Effects Reduced by Dietary Changes

Saturday, March 30th, 2013

OAB, which stands for overactive bladder, is an uncomfortable and often frustrating medical condition with symptoms like incontinence, frequent need to urinate, and nocturia, where the patient gets up multiple times at night to urinate. However, the National Association for Continence (NAFC) suggests that some changes in the patient’s diet may help ease some of [...]

Vitamin D may be helpful in Diabetes Prevention

Friday, March 29th, 2013

Vitamin D, a mineral that is important for protecting the body against heart disease, asthma, weak bones, and other health conditions, may be effective in preventing diabetes, according to a recent study. Scientists involved in the study recently discovered that adequate vitamin D consumption among young people can reduce the risk of diabetes by up [...]

Native American Lupus Patients have Greater Kidney Risks

Thursday, March 28th, 2013

Kidney damage is one of the biggest complications associated with lupus, and some patients have a higher risk of suffering from it than others. A recent study suggests that Native American ancestry may be linked to this increased risk among some patients. The study also shows that Native American ancestry may protect the patients from [...]

Traffic Light System for Infection Severity Check Not Good Enough

Wednesday, March 27th, 2013

A ‘traffic light’ system has been used for classifying the infection severity among children and young patients diagnosed with serious bacterial infections. However, this system is not enough for detecting various types of infections, especially urinary tract infections, according to a recent study.
Despite the results, the researchers noted that a urine analysis can significantly improve [...]

Syphilis Still Common in Pregnancy

Tuesday, March 26th, 2013

Despite the widespread availability and affordability of syphilis tests and treatment, the condition is still common among pregnant women around the world, according to a recent study.
The study was done by Lori Newman and colleagues from the World Health Organization, Geneva. She said, “This analysis indicates that syphilis continues to be an important cause of [...]

Subclinical Inflammation May Predict Macular Degeneration and Edema

Monday, March 25th, 2013

Results of two recent independent studies show that the level of hsCRP or high-sensitivity C-reactive protein may predict the risk of diabetic macular edema and age-related macular degeneration or AMD. These results are quite significant because they indicate that subclinical inflammation may be an underlying mechanism and a risk marker, and raise the possibility of [...]

Narcolepsy Linked to Swine Flu Vaccine in England

Sunday, March 24th, 2013

Researchers of a U.K. study have reported an increased risk of narcolepsy among children who were given the swine flu vaccine in the country. They estimate that one in 52,000-57,500 vaccine doses is associated with the development of this condition. The vaccine in question is the AS03 adjuvanted pandemic A/H1N1 2009, which has been offered [...]

Lack of Awareness Hinder Access to HF Palliative Care

Saturday, March 23rd, 2013

Findings from a recent U.S. study show that lack of awareness among patient diagnosed with heart failure (HF) prevents them from access to the necessary palliative care service needed during the late stages. Many of them confuse palliative with hospice care, and they often reject the latter because they fear it will prevent them from [...]

GLP-1 Therapy for Diabetes Associated with Pancreatitis Risk

Friday, March 22nd, 2013

A recent study has shed light on a link between glucagon-like peptide-1 (GLP-1) treatment for type 2 diabetes and pancreatitis. The findings of the study show that patients prescribed with exanatide and sitagliptin have twice the risk of getting admitted in the hospital due to acute pancreatitis that other type 2 diabetes patients.
This study involved [...]

« Previous Entries